The anesthetics are a supplied items and the complaint notification was forwarded to the supplier.Batch record review performed by the supplier for bupivacaine lot #582453a revealed no discrepancies that may have contributed to a complaint of this nature.Final release potency testing for all drug components was performed and was within specification requirements.Retained file samples testing performed by the supplier met specification.See attached hospira's evaluation report.Possible causes of lack of effect may be administration technique or patient anatomical variations, including pathological or psychological factors.The complaint could not be confirmed.
|